Brief: Karolinska Development's Unit To Collaborate With University College London
Oct 19 (Reuters) - Karolinska Development AB KDEV.ST :
* KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY UMECRINE
COGNITION TO
COLLABORATE WITH UNIVERSITY COLLEGE LONDON TO INCREASE INSIGHTS
ABOUT GOLEXANOLONE
* KAROLINSKA DEVELOPMENT'S OWNERSHIP INTEREST IN UMECRINE
COGNITION AMOUNTS TO 70%
Source text for Eikon: ID:nGNEBpcDH
Further company coverage: KDEV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue